[1] Plichta DR, Graham DB, Subramanian S, et al. Therapeutic opportunities in inflammatory bowel disease: mechanistic dissection of host-microbiome relationships[J].Cell, 2019, 178(5):1041-1056. [2] Grant A,Crane M,Laupacis A,et al. Engaging patients and caregivers in research for pediatric inflammatory bowel disease: top 10 research priorities[J]. J Pediatr Gastroenterol Nutr, 2019, 69(3):317-323. [3] 王植,张乐,杨蒙香,等. 维生素D与代谢综合征的研究进展[J]. 中国医师进修杂志,2019,42(1):88-90. [4] 张爱飞,冯正平. 维生素D免疫调节的研究进展[J]. 中国骨质疏松杂志,2019,25(4):564-569. [5] 陈风慧,王晓华,范春梅. 补充外源性维生素D对老年溃疡性结肠炎患者氧化-抗氧化失衡、肠道黏膜屏障和临床预后的影响[J]. 陕西医学杂志,2018,47(12):1634-1637. [6] 中华医学会消化病学分会炎症性肠病学组. 炎症性肠病诊断与治疗的共识意见(2012年·广州)[J]. 中华内科杂志,2012,51(10):818-831. [7] Zundler S, Becker E, Schulze LL, et al. Immune cell trafficking and retention in inflammatory bowel disease: mechanistic insights and therapeutic advances[J]. Gut, 2019, 68(9):1688-1700. [8] Özdemir RB, Özdemir AT, Sariboyac AE, et al. The investigation of immunomodulatory effects of adipose tissue mesenchymal stem cell educated macrophages on the CD4 T cells[J]. Immunobiology, 2019, 224(4):585-594. [9] Hessov I, Mosekilde L, Melsen F, et al. Osteopenia with normal vitamin D metabolites after small-bowel resection for Crohn's disease[J]. Scandinavian J Gastroenterol, 1984, 19(5):691-696. [10] Joseph AJ, George B, Pulimood AB, et al. 25 (OH) vitamin D level in Crohn's disease: association with sun exposure & disease activity[J]. Indian J Med Res, 2009, 130(2):133-137. [11] Al-Shamma H,Lehmann-Bruinsma K,Carroll C,et al. The selective sphingosine 1-phosphate receptor modulator etrasimod regulates lymphocyte trafficking and alleviates experimental colitis[J]. J Pharmacol Exp Ther, 2019, 369(3):311-317. [12] 王晖,黄海涛,梁三红,等. 英夫利西单抗联合硫唑嘌呤片对炎症性肠病患者T淋巴细胞的影响[J]. 实用药物与临床,2017,20(9):1039-1042. [13] Martins F, Sofiya L, Sykiotis GP, et al. Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance[J]. Nat Rev Clin Oncol, 2019, 16(9):563-580. [14] Shi X, Yang W, Wang N, et al. Circulating JNK pathway-associated phosphatase level correlates with decreased risk, activity, inflammation level and reduced clinical response to tumor necrosis factor-α inhibitor in Crohn disease patients[J]. Medicine (Baltimore), 2019, 98(33):e16622. [15] 李毅,刘艳,闫曙光,等. 调肠经典三方对UC大鼠结肠细胞因子IL-17、IL-23、IL-6、IL-10及TNF-α的影响[J]. 现代中西医结合杂志,2017,26(9):920-924. [16] Luo W, Shen Z, Deng M, et al. Roseburia intestinalis supernatant ameliorates colitis induced in mice by regulating the immune response[J]. Mol Med Rep, 2019, 20(2):1007-1016.
2021, Vol. 28 
